Status:
COMPLETED
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
Lead Sponsor:
GC Cell Corporation
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
20-80 years
Brief Summary
To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea
Eligibility Criteria
Inclusion
- Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent.
- Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial.
Exclusion
- Patient who is incongruent to this clinical trial by sub-investigator's opinion.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT01890291
Start Date
June 1 2013
End Date
February 1 2016
Last Update
June 26 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National Hospital
Seoul, South Korea, 110-744
2
Samsung Medical Center
Seoul, South Korea, 135-710
3
Asan Medical Center
Seoul, South Korea, 138-736
4
Korea University Guro Hospital
Seoul, South Korea, 152-703